GoodRx Holdings, Inc. (GDRX) News
Follow GoodRx Holdings, Inc. (GDRX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
GoodRx Q3 Results Preview: Revenue Estimate Provided
GoodRx is scheduled to report Q3 results on November 10. Revenue and EPS estimates are provided; the release time is not specified.
EQUITY | Nov 03, 2026, 12:01 PM UTC
M
GoodRx Says Q1 and Q2 2026 Financial Statements Should Not Be Relied Upon
EQUITY | Nov 02, 2026, 09:39 PM UTC
M
GoodRx to Restate First-Half 2026 Financials Overstating Revenue
GoodRx Holdings plans to restate its first-half 2026 financials because revenue was understated.
EQUITY | Nov 02, 2026, 09:38 PM UTC
H
Full Transcript: GoodRx Holdings Q2 2026 Earnings Call
GoodRx Holdings (NASDAQ: GDRX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data.
LIVE | Oct 05, 2026, 11:12 AM UTC
L
Amazon, GoodRx target US prescription subscribers as health insurance coverage slips
By Amina NiasseAmazon.com NASDAQ:AMZN, GoodRx NASDAQ:GDRX and other companies offering online subscriptions that charge a flat fee for prescription drugs and other health services are reaping the benefits of Americans lo
NEWS | Sep 29, 2026, 10:00 AM UTC
L
GoodRx launches Companion Family Plan for household, including pets
GoodRx (Nasdaq: GDRX) launched the GoodRx Companion Family Plan, expanding its everyday healthcare subscription to cover the entire family, including pets, amid widening coverage gaps and rising out-of-pocket costs.
EQUITY | Sep 03, 2026, 01:00 PM UTC
L
Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $5
Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ: GDRX ) with a Buy and raises the price target from $4 to $5.
EQUITY | Aug 11, 2026, 08:07 PM UTC
L
GoodRx Holdings Raises FY2026 Sales Guidance from $765.000M-$785.000M to $790.000M-$805.000M vs $775.751M Est
GoodRx Holdings (NASDAQ: GDRX ) raises FY2026 sales outlook from $765.000 million-$785.000 million to $790.000 million-$805.000 million vs $775.751 million estimate.
EARNINGS | Aug 05, 2026, 08:38 PM UTC
L
GDRX Reports Q2 Net Income $8.5m
GDRX Q2 net income is $8.5m
EARNINGS | Aug 05, 2026, 08:19 PM UTC